p21 expression is a prognostic factor in patients with p53-negative gastric cancer
Authors:
- Takashi AikouTATakashi Aikou
- 1 February 2000
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 148 (2) , 181-188
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 18 references indexed in Scilit:
- p53 and p21WAF1Expression in Lymphocytic Thyroiditis and Thyroid TumorsClinical Immunology and Immunopathology, 1998
- Induction of p21 during ceramide-mediated apoptosis in human hepatocarcinoma cellsCancer Letters, 1998
- Expression of p21(waf1/cip1) Protein in Transitional Cell Bladder Tumours and Its Prognostic ValueEuropean Urology, 1998
- Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines withp21/WAF1/CIP1 and/orp53 gene alterationsInternational Journal of Cancer, 1996
- Inhibition of Cell Growth by Transforming Growth Factor β1 Is Associated with p53‐Independent Induction of p21 in Gastric Carcinoma CellsJapanese Journal of Cancer Research, 1996
- Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1Nature, 1995
- p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.Genes & Development, 1995
- p53-Independent Expression of p21 Cip1 in Muscle and Other Terminally Differentiating CellsScience, 1995
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993